Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News Why acute stress disorder may become the next major neuroscience opportunity for BXCL501 Could BXCL501 open a major new neuroscience market in acute stress disorder? Read what this means for BioXcel Therapeutics and investors. bySoujanya RaviApril 10, 2026